REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
8.82
-0.24 (-2.65%)
At close: Aug 15, 2025, 3:59 PM
8.91
0.96%
After-hours: Aug 15, 2025, 06:29 PM EDT
REGENXBIO Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 155.78M | 156.72M | 83.33M | 84.33M | 89.04M | 86.73M | 90.24M | 99.37M | 96.97M | 109.64M | 112.72M | 480.03M | 484.3M | 473.68M | 470.35M | 93.14M | 161.28M | 155.81M |
Cost of Revenue | 31.25M | 36.77M | 41.8M | 51.05M | 51.05M | 45.9M | 41.55M | 38.76M | 39.46M | 42.94M | 54.55M | 64.82M | 65.83M | 62.7M | 51.83M | 39.03M | 42.29M | 37.16M |
Gross Profit | 124.53M | 119.95M | 41.53M | 33.27M | 37.99M | 40.83M | 48.69M | 60.62M | 57.51M | 66.7M | 58.18M | 415.21M | 418.46M | 410.98M | 418.51M | 54.1M | 118.98M | 118.65M |
Operating Income | -164.6M | -157.36M | -231.25M | -243.78M | -246.66M | -263.73M | -268.13M | -262M | -268.08M | -257.51M | -262.88M | 108.49M | 122.19M | 132.5M | 159.98M | -207.27M | -135.97M | -125.58M |
Interest Income | 3.51M | 137K | 174K | 2.46M | 2.49M | 2.5M | 2.53M | 243K | 205K | 318K | 342K | 284K | 383K | 784K | 719K | 830K | 2.16M | 3.45M |
Pretax Income | -175.57M | -157.69M | -227.1M | -238.96M | -241.23M | -260.3M | -263.65M | -260.58M | -274.2M | -270.32M | -280.4M | 87M | 104.08M | 114.62M | 141.25M | -206.68M | -139.48M | -116.11M |
Net Income | -175.57M | -157.69M | -227.1M | -238.81M | -241.08M | -260.15M | -266.77M | -263.81M | -281.87M | -277.99M | -284.76M | 69.2M | 90.72M | 101.26M | 127.84M | -212.42M | -145.23M | -121.35M |
Selling & General & Admin | 79.7M | 78.67M | 76.62M | 75.65M | 79.31M | 84.15M | 88.49M | 90.63M | 88.46M | 85.6M | 85.28M | 86.11M | 86.22M | 83.81M | 79.33M | 74.86M | 69.69M | 66.82M |
Research & Development | 213.49M | 202.71M | 200.29M | 201.26M | 205.01M | 220.08M | 227.93M | 239.09M | 244.22M | 245.34M | 242.45M | 227.93M | 212.47M | 197.34M | 181.44M | 180.64M | 176.75M | 168.98M |
Other Expenses | -4.07M | -4.14M | -4.13M | -76K | 107K | 162K | 161K | -7.1M | -7.09M | -7.51M | -7.46M | 43.74M | 48.64M | 49.16M | 49.6M | 5.87M | 8.51M | 8.42M |
Operating Expenses | 289.12M | 277.3M | 272.77M | 277.05M | 284.65M | 304.56M | 316.82M | 322.61M | 325.59M | 324.21M | 321.06M | 306.72M | 296.28M | 278.49M | 258.53M | 261.37M | 254.95M | 244.23M |
Interest Expense | 12.66M | 2.12M | 12.66M | 4.61M | 5.41M | 6.08M | 6.86M | 9.81M | 14.14M | 19.88M | 23.25M | 25.44M | 26.2M | 25.7M | 26.28M | 20.55M | 13.84M | 7.47M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 320.38M | 314.07M | 314.57M | 328.11M | 335.71M | 350.46M | 358.37M | 361.37M | 365.05M | 367.15M | 375.6M | 371.54M | 362.11M | 341.19M | 310.37M | 300.4M | 297.24M | 281.38M |
Income Tax Expense | n/a | n/a | n/a | -152K | -152K | -152K | 3.12M | 3.23M | 7.67M | 7.67M | 4.36M | 17.8M | 13.36M | 13.36M | 13.41M | 5.75M | 5.74M | 5.24M |
Shares Outstanding (Basic) | 51.48M | 51.36M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M | 43.45M | 43.3M | 43.25M | 43.11M | 42.94M | 42.77M | 42.63M | 42.51M | 41.82M |
Shares Outstanding (Diluted) | 51.48M | 51.43M | 50.87M | 50.8M | 50.6M | 45.73M | 44M | 43.95M | 43.53M | 43.45M | 43.3M | 43.25M | 43.11M | 42.94M | 44.08M | 42.63M | 42.51M | 41.82M |
EPS (Basic) | -3.44 | -3.11 | -4.61 | -5.03 | -5.27 | -5.88 | -6.11 | -6.06 | -6.5 | -6.42 | -6.6 | 1.65 | 2.13 | 2.35 | 2.94 | -5.17 | -3.56 | -3.11 |
EPS (Diluted) | -3.44 | -3.11 | -4.61 | -5.03 | -5.27 | -5.88 | -6.11 | -6.06 | -6.5 | -6.42 | -6.6 | 1.45 | 1.93 | 2.15 | 2.74 | -5.17 | -3.57 | -3.12 |
EBITDA | -129.93M | -122.44M | -198.23M | -217.82M | -218.88M | -236.9M | -239.46M | -233.66M | -243.77M | -235.94M | -244.24M | 123.5M | 140.62M | 150.22M | 176.76M | -177.07M | -117.23M | -100.29M |
EBIT | -145.77M | -138.43M | -214.44M | -234.35M | -235.82M | -254.22M | -256.78M | -250.77M | -260.06M | -250.44M | -257.15M | 112.11M | 129.95M | 139.99M | 167.19M | -186.13M | -120.48M | -103.47M |
Depreciation & Amortization | 15.84M | 15.99M | 16.21M | 16.53M | 16.94M | 17.32M | 17.32M | 17.11M | 16.29M | 14.5M | 12.91M | 11.39M | 10.67M | 10.23M | 9.56M | 9.06M | 8.41M | 8.34M |